| NUVL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the NUVL shares outstanding history going back to 8/31/2021:
Also see: NUVL Market Cap History NUVL YTD Return |
As of 4/30/2026 Nuvalent has 73.56 million NUVL shares outstanding. Investors often track the NUVL shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NUVL share count trends over time, with 18 historical shares outstanding datapoints presented, dating back to 8/31/2021.

| NUVL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the NUVL shares outstanding history going back to 8/31/2021:
Also see: NUVL Market Cap History NUVL YTD Return |
| NUVL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||
NUVL Historical Shares Outstanding: +12.28% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||
| NUVL Stock Price Chart |
| About Nuvalent Inc |
| Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases and drive more durable responses. It is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-positive non-small cell lung cancer, and multiple discovery-stage research programs. Its product candidate, NVL-520, is being developed for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC). NVL-520 is a novel ROS1-selective inhibitor. We show 18 historical shares outstanding datapoints in our coverage of NUVL's shares outstanding history. Understanding the changing numbers of NUVL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NUVL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NUVL by allowing them to research NUVL shares outstanding history as well as any other stock in our coverage universe. |
| NUVL Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| NUVL Share Performance |
| Shares Outstanding Peers |
| Nuvalent (NUVL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NUWE Shares Outstanding History NVAX Shares Outstanding History NVCT Shares Outstanding History NVIV Shares Outstanding History NVNO Shares Outstanding History NVO Shares Outstanding History NVOS Shares Outstanding History NVRO Shares Outstanding History NVST Shares Outstanding History NVTA Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.